Vishnya Stoyanova

Dr. Vishnya Stoyanova


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Nadezhda TodorovaNadezhda Todorova
Nadezhda Todorova
MRMiroslav Rangelov
Miroslav Rangelov
VBVanya Petkova Bogoeva
Vanya Petkova Bogoeva
VSVishnya Stoyanova
Vishnya Stoyanova
AYAnna Yordanova
Anna Yordanova
ITIvanka Tsacheva
Ivanka Tsacheva
We addressed the issue of C1q autoantigenicity by studying the structural features of the autoepitopes recognized by the polyclonal anti-C1q antibodies present in Lupus Nephritis (LN) sera. We used six fractions of anti-C1q as antigens and selected anti-idiotypic scFv antibodies from the phage library “Griffin.1”. The monoclonal scFv A1 was the most potent inhibitor of the recognition of C1q and its fragments ghA, ghB and ghC, comprising the globular domain gC1q, by the lupus autoantibodies. It was sequenced and in silico folded by molecular dynamics into a 3D structure. The generated 3D model of A1 elucidated CDR similarity to the apical region of gC1q, thus mapping indirectly for the first time a globular autoepitope of C1q. The VH CDR2 of A1 mimicked the ghA sequence GSEAD suggested as a cross-epitope between anti-DNA and anti-C1q antibodies. Other potential inhibitors of the recognition of C1q by the LN autoantibodies among the selected recombinant antibodies were the monoclonal scFv F6, F9 and A12.

1 October 2020 in Journal of IMAB – Annual Proceeding (Scientific Papers)
Verified
Journal Article
Closed access
VSVishnya Stoyanova
Vishnya Stoyanova
ATAsya Tsanova
Asya Tsanova
AJAlbena Jordanova
Albena Jordanova
NJNeli Jekova
Neli Jekova
DSDetelina Stoichkova
Detelina Stoichkova
EHEmilia Hristova
Emilia Hristova